SLC12A3 and Gitelman syndrome: The phenotype of both, type I Bartter syndrome and Gitelman syndrome patients, is exclusively the consequence of the lack of activity of these transporters in the nephron, suggesting that indeed their expression is very restricted to the kidney and, if expressed elsewhere, like NCC in bone, its role in other tissues is not essential.